"New Jersey is home to eight of the top 10 global biopharmaceutical companies, nine of the top 10 R&D firms, and over 5,600 life sciences establishments. The State accounted for 43% of all novel FDA approvals in the past two years."
"Procos is poised for transformative growth in 2025. Our R11 facility will significantly enhance our small-scale production capacity, enabling us to meet the growing demand for high-quality, specialized APIs in the US market."
"By developing intra-African energy infrastructure, we can reduce costs, improve energy access, and encourage local refining and petrochemical industries."
"The growth of infrastructure and allocation of state budgets over the last several administrations have spurred significant growth in newly industrialized areas."
“Our strategy is straightforward: acquire underperforming assets, inject capital, bring in the right expertise, and turn these assets around, making them more investable.”
"The current status quo is focusing on how we mechanize mines to maintain or increase productivity, while getting people out of the mines into safer working environments."
"In manufacturing, there are only two ways to increase capacity: add a second shift and invest in technology. We have undertaken both of these at B&D Manufacturing."
“Hemos optado por desarrollar nuestro propio software de control de calidad y procesamiento geofísico, ya que preferimos crear nuestras propias soluciones en lugar de depender de un software comercial.”
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.